Italy - Medicines for blood and blood-forming organs - Negotiated procedure by AAST_AN, as availing entity of the aggregator, for a single-award framework agreement for the exclusive medicine Altuvoct (efanesoctocog alfa)

01

A negotiated tender launched by AAST_AN (Azienda Speciale per i Servizi Sanitari di Ascoli Piceno), acting as an availing entity of the aggregator, to conclude a single-award framework agreement for supplying the exclusive medicine Altuvoct P.A. (efanesoctocog alfa), a medicine for blood and blood-forming organs. The supply is intended for entities of the Italian National Health Service, in this case the Hospital University Company of the Marche, following act no. 409/DG of 07/05/2026. Documentation is available for download on the contracting authority's website.

02

Description

03

1 open tender right now

• Reagents and contrast media - Open procedure for the in-service supply of an automated molecular testing system for the diagnosis of acute and chronic leukaemia 14 Oct 2026 · 17 days left

Who usually wins this buyer's contracts in this sector

Based on 5 awards with a linked company profile over the last 5 years.

04

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

1. 5 Aug 2026 Read before bidding
   • Estimated value: Set to €487,512
   • Estimated value: Set to €487,512

Follow this tender and we email you the moment it changes. Create account

06

Market context

Avg. open tender · Medical equipment & pharmaceuticals

€10,020,608

9,792 open across Europe right now 95% below sector average

Buyer track record on Aperlena

28 notices tracked · 8 awarded

€92,283,441 in awarded contracts